Nanjing Vazyme Biotech Co Ltd Cash Flow Quality Index
Nanjing Vazyme Biotech Co Ltd cash flow quality index. Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow Quality Index of 21.60x as of September 2025. Operating cash flow of CN¥75.30 Million exceeds net income of CN¥3.49 Million, indicating high earnings quality where cash backs reported profits. See 688105 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Nanjing Vazyme Biotech Co Ltd (2017–2022)
Cash flow quality index of Nanjing Vazyme Biotech Co Ltd from 2017 to 2022. Historical Cash Flow Quality Index for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 688105 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Nanjing Vazyme Biotech Co Ltd Cash Flow Quality Index by Year (2017–2022)
Nanjing Vazyme Biotech Co Ltd cash flow quality index by year from 2017 to 2022. Year-by-year earnings quality comparison for Nanjing Vazyme Biotech Co Ltd. For the full cash flow conversion analysis, see 688105 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.24x | CN¥735.17 Million | CN¥593.51 Million | ▲ +36.2% |
| 2021 | 0.91x | CN¥616.80 Million | CN¥678.29 Million | ▼ -7.0% |
| 2020 | 0.98x | CN¥803.55 Million | CN¥821.73 Million | ▲ +65.9% |
| 2019 | 0.59x | CN¥15.20 Million | CN¥25.79 Million | ▲ +115.3% |
| 2018 | -3.85x | CN¥-4.00 Million | CN¥1.04 Million | ▼ -263.5% |
| 2017 | -1.06x | CN¥-3.86 Million | CN¥3.64 Million | — |